| 摘要 |
<p>Disclosed is a therapeutic agent for attention deficit/hyperactivity disorder, which has a novel mechanism of action that is difference from those of conventional central nervous system stimulating agents. Specifically disclosed is an excellent pharmaceutical composition for preventing and/or treating attention deficit/hyperactivity disorder, which comprises a BEC1 potassium channel inhibitor or a pharmaceutically acceptable salt thereof as an active ingredient, particularly a pharmaceutical composition for preventing and/or treating inattention, impulsivity, hyperactivity and the like in attention deficit/hyperactivity disorder.</p> |
